Substance / Medication

Testosterone propionate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

13 trials linked to this intervention

13
Total Trials
3
Recruiting
4
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Determination of Steroids in Bovine Serum: Validation of a Reliable LC-MS/MS Method and In Vivo Studies with Boldenone Undecylenate and Testosterone Propionate.
Rocha Diego G, Lana Mary Ane G, de Assis Débora C S et al. · J Agric Food Chem · 2020
PMID: 32960588Observational
High-dose testosterone propionate treatment reverses the effects of endurance training on myocardial antioxidant defenses in adolescent male rats.
Sadowska-Krępa Ewa, Kłapcińska Barbara, Jagsz Sławomir et al. · Cardiovasc Toxicol · 2011
PMID: 21312070ObservationalFull text (PMC)
The anabolic steroids testosterone propionate and nandrolone, but not 17alpha-methyltestosterone, induce conditioned place preference in adult mice.
Parrilla-Carrero Jeffrey, Figueroa Orialis, Lugo Alejandro et al. · Drug Alcohol Depend · 2009
PMID: 19028026ObservationalFull text (PMC)
[Effect of testosterone propionate on the distribution pattern of calcitonin gene-related peptide in different motoneuron pools].
Shi Ge-ming, Li Shuang-cheng, Zhang Kai et al. · Zhongguo Yi Xue Ke Xue Yuan Xue Bao · 2005
PMID: 16447649Observational
Analysis of Methyltestosterone and Testosterone Propionate in Dried Blood Spots After Transdermal Application.
Miyamoto Asami, Okano Masato, Ota Masanori et al. · Drug Test Anal · 2025
PMID: 40474335Other
Characteristics of polycystic ovary syndrome rat models induced by letrozole, testosterone propionate and high-fat diets.
Hu Runan, Huang Yanjing, Liu Zhuo et al. · Reprod Biomed Online · 2025
PMID: 39626468Preclinical
Effect of Fenugreek Extract on Testosterone Propionate-Induced Benign Prostatic Hyperplasia.
Lee Jeong Yoon, Bang Jiyoung, Kim Jinhak et al. · Int J Mol Sci · 2025
PMID: 39941027PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Testosterone propionate (substance)
SNOMED CT
96338002
UMLS CUI
C0039607

Clinical Data

This intervention maps to 10 entities in the Healos knowledge graph.

4
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
13
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.